Under the hypothesis presented here, the anti- α4β7 antibody likely helped to control simian immunodeficiency virus infection after antiretroviral drug cessation by encouraging CD4 T cells to traffic away from gut-associated lymphoid tissue, to other tissue sites that have high concentrations of antiretroviral drugs. The gene discussed is CD4; the disease is simian immunodeficiency virus infection.